Search

Jan 16, 2024
Jefferies analyst Michael Yee previews the year ahead, the outlook for M&A, and dives into top picks
Michael Yee shares takeaways from last week's conference in San Francisco and highlights his top names to watch.


Aug 3, 2023
Jefferies’ Michael Yee joins BiotechTV for Analyst Thursdays
Michael Yee gives his take on biotech and discusses Vertex, Ventyx Biosciences, ALX Oncology, Akero, and Prothena.